MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Pharmaceutical Executive
March 1, 2011
Jerry Coamey
Engage the Physician! New research shows that gauging the mind of the clinician is crucial to timely uptake of the new diagnostic tools offered by the genomic revolution mark for My Articles similar articles
Fast Company
David Lumb
Sites That Sell Cancer Gene Tests Don't Tell Customers The Whole Story, Study Finds Consumer tests that analyze DNA from tumors in order to help personalize a patient's treatment are in something of a Wild West period. mark for My Articles similar articles
The Motley Fool
February 4, 2010
Brian Orelli
Surfing the Wave of the Future: Personalized Medicine Medco buys in to personalized medicine. Yesterday Medco Health Solutions said it's purchasing genetic-testing expert DNA Direct. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2010
The Testing of the Tests FDA seeks to regulate genetic tests more actively, while encouraging diagnostic development. mark for My Articles similar articles
Chemistry World
July 2010
Anna Lewcock
Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition. mark for My Articles similar articles
Chemistry World
February 25, 2015
Rebecca Trager
US opens up home DNA screening The US Food and Drug Administration has, for the first time, authorized a genetic test to be sold directly to consumers. The agency plans to ease the regulatory path for similar screening tests. mark for My Articles similar articles
The Motley Fool
June 14, 2010
Bruce Bigelow
Genetic Testing Companies in San Diego, Boston, and San Francisco Studying FDA Letters The letters notify the companies that genome-sequencing tests they offer to consumers are medical devices that require the agency's approval. mark for My Articles similar articles
Managed Care
May 2001
Michael D. Dalzell
Powerful Opportunities For Good and Greed Genetic advances could spawn incredible improvements in health care. Given public demand, they also pose what may be unmanageable issues of resource use... mark for My Articles similar articles
Bio-IT World
March 17, 2004
Zachary Zimmerman
Testing Times for the FDA The FDA's pharmacogenomic guidance marks the beginning of a long process toward standardized tests. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2011
Don Creighton
Bridging the Hidden Hurdle in Cancer Cures Diagnostics can boast the efficacy of drug treatments, but delivering the promise depends on a predictable pathway to reimbursement. mark for My Articles similar articles
Bio-IT World
August 13, 2003
John Rhodes
Beyond the Blockbuster Genomics and big hits are not mutually exclusive, writes Deloitte & Touche's life sciences expert. mark for My Articles similar articles
The Motley Fool
December 30, 2008
Brian Orelli
A Post-Holiday Breakup ... of Sorts Abbott and Celera revise their partnership. mark for My Articles similar articles
The Motley Fool
May 28, 2010
Brian Orelli
Is It Time to Make Money Investing in Genetic Testing? Easier said than done. mark for My Articles similar articles
The Motley Fool
July 9, 2008
Brian Lawler
Predicting More Good News From Invitrogen Invitrogen gets a positive review from the FDA for one of its tests. mark for My Articles similar articles
Chemistry World
September 11, 2013
Emma Stoye
Call to overhaul liver toxicity testing Outdated assays for monitoring liver health could have caused dozens of drug candidates to be wrongly scrapped during development, according to new research. mark for My Articles similar articles
Managed Care
November 2006
Maureen Glabman
Genetic Testing: Major Opportunity, Major Problems Whether a person is likely to develop diabetes, cancer, schizophrenia, or stroke will be reasonably well predicted, and tests can also determine whether a patient will respond to a given therapy. That's the good part. mark for My Articles similar articles
The Motley Fool
June 20, 2008
Brian Orelli
Live From Bio: Personalized Medicine The movement is chugging along thanks to diagnostics. mark for My Articles similar articles
Fast Company
David Lumb
The FDA Just OK'd 23AndMe To Test For One Syndrome The FDA just gave consumer genetics testing company 23AndMe permission to sell tests for Bloom syndrome -- a disease associated with shortened height and an increased cancer risk. mark for My Articles similar articles
Bio-IT World
December 15, 2003
Kevin Davies
The Road to Personalized Medicine FDA guidance on the road to genomic medicine is a welcome first step in what promises to be a contentious debate on how to integrate pharmacogenomics into routine medical practice. mark for My Articles similar articles
Pharmaceutical Executive
February 1, 2013
William Looney
In Cancer, Process Drives Progress Today's most important public health story is the advance in our understanding of the biology of cancer. mark for My Articles similar articles
BusinessWeek
September 5, 2005
Kerry Capell
Meeting Leukemia's Diagnostic Challenge Tests that distinguish among the disease's many forms either cost too much or don't exist. Dr. Torsten Haferlach And Switzerland's Roche Diagnostics may have a solution. mark for My Articles similar articles
Chemistry World
March 2, 2007
Arthur Rogers
Drug Misuse Under Investigation European drug crime experts have been commissioned by the Council of Europe Parliamentary Assembly to investigate ways of combating the increased use of date rape drugs such as Rohypnol. mark for My Articles similar articles
Managed Care
September 2002
Aetna Chief Wants Coverage For Genetic Tests The CEO of the country's largest for-profit HMO has jumped with both feet into the national discussion about genetic testing's place in health care. mark for My Articles similar articles
Managed Care
May 2005
Martin Sipkoff
Predictive Modeling & Genomics: Marriage of Promise and Risk Integration of predictive modeling and genomic tools means improved technology, enhanced databases, and appropriate legal guidance. mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2006
Nancy Dreyer
Personalized Medicine Meets the Real World A wave of genomic medicines is coming down the pipeline, and they're going to be expensive. Can companies prove they're worth it? Maybe: but the claims payers seek aren't coming from traditional clinical trials. mark for My Articles similar articles
BusinessWeek
September 5, 2005
Capell & Arndt
Drugs Get Smart Future medicines will more effectively target what ails you by tailoring treatment to your specific genetic profile. Personalized medicine will also help prevent another Vioxx. mark for My Articles similar articles
Bio-IT World
November 14, 2003
Kathy Ordonez
Targeted Medicine via Molecular Diagnostics Using diagnostics to select and deselect target populations for drug therapy will enable life scientists to make more effective medicines. mark for My Articles similar articles
Managed Care
April 2005
Michael Levin-Epstein
Time To Decipher Legislation's DNA Health plans have much at stake as Congress moves to lay down the do's and don'ts about use of info gathered via genetic testing. mark for My Articles similar articles
The Motley Fool
September 7, 2007
Brian Orelli
Clinical Data Gets Personal Clinical Data's lead compound Vilazodone posts strong phase 3 results. The company is searching for common genetic markers among patients who responded positively to the drug. mark for My Articles similar articles
The Motley Fool
March 31, 2010
Brian Orelli
When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies. mark for My Articles similar articles
Managed Care
June 2001
Darcy Lewis
National Guideline Clearinghouse: Extensive Resource Underused It's there on the Web, highly convenient. What keeps physicians away? mark for My Articles similar articles
Managed Care
September 2004
Tony Berberabe
Can Physician and Health Plan Get Together Over Guidelines? Physicians are not the only problem. Health plans too often view guidelines as rigid routines rather than flexible aids to good practice. mark for My Articles similar articles
Fast Company
September 2000
John Ellis
The Secret of Life The mapping of the human genome, says Craig Venter, will change science, research, medicine, politics, health insurance, and the way biology looks at the last 3 billion years of evolution. And that's just the beginning. mark for My Articles similar articles
Entrepreneur
January 2006
Jacquelyn Lynn
The DNA Dilemma Should genetic discrimination be part of your employment practices liability insurance coverage? mark for My Articles similar articles
The Motley Fool
October 27, 2010
Ralph Casale
Companion Diagnostics in Cancer Drug Development Diagnostic companies partnering with drug developers can make for an attractive investment segment. mark for My Articles similar articles
AskMen.com
Jacob Franek
Genetic Testing Every day the prospect of individualized genetic testing is slowly becoming commonplace, and certain questions about genetic testing are apparent: What kinds of tests are available? Where can I get them? How accurate are they? And what are the costs? mark for My Articles similar articles
Bio-IT World
February 2007
Kevin Davies
Obama Declares for Personalized Medicine Barack Obama is one of few members of congress who sees the genomics tidal wave and is doing something about it. Obama may be a Democrat, but drug and biotech industries have reason to hope. mark for My Articles similar articles
The Motley Fool
September 28, 2007
Brian Orelli
Side Effects No Match for This Tag Team Seven large drugmakers have come together to try and find genetic variations that cause medications to have serious side effects in some patients, but not in others. mark for My Articles similar articles
Fast Company
January 2002
George Anders
Roche's New Scientific Method How does a giant pharmaceutical company reckon with genomics technology? By making a fresh start in how it recruits its scientists, manages projects, and uses computers. Here's how the Roche Group is reinventing how it invents... mark for My Articles similar articles
The Motley Fool
September 24, 2007
Jack Uldrich
Nanotech Is in the Genes The FDA's stamp of approval on a genetic test that will help patients better understand how they will metabolize anti-blood clot medication gives Nanosphere extra allure. Investors should take note. mark for My Articles similar articles
Chemistry World
May 29, 2014
Darren Smyth
We need to talk about Nagoya On 14 April 2014, the Council of the EU adopted a regulation that will affect researchers throughout Europe, by enabling ratification of the Nagoya Protocol. mark for My Articles similar articles
Fast Company
Elizabeth Segran
23andMe And The FDA Reached A Pivotal Genetic Testing Agreement An FDA decision summary allows DNA-testing company 23andMe to market a genome test that screens for Bloom syndrome, a rare disorder that may lead toward the development of cancer. mark for My Articles similar articles
Chemistry World
December 24, 2014
Rebecca Trager
FBI's 2001 anthrax investigation was flawed The scientific evidence that the US Federal Bureau of Investigation relied upon to investigate the October 2001 anthrax attacks was deeply flawed, according to a new report. mark for My Articles similar articles
Nurse Practitioner
February 2010
Andrews et al.
ARVC: Help prevent sudden death Arrhythmogenic right ventricular cardiomyopathy is a dangerous condition that can cause sudden death. mark for My Articles similar articles
The Motley Fool
August 17, 2007
Brian Orelli
FDA's Rigor May Boost Sales The FDA is updating labeling of certain blood-thinning drugs, indicating that patients may want to obtain a genetic test prior to taking the medication. This move may lead to increased testing, and hopefully increased prescriptions. mark for My Articles similar articles
The Motley Fool
August 24, 2007
Brian Orelli
Take Your Medicine; Earn Your Profits Personalized medicine offers investment ideas. Let's take a look at what this new catchphrase in the medical community actually means, and how investors can benefit from it. mark for My Articles similar articles
IEEE Spectrum
March 2013
Eliza Strickland
The Gene Machine and Me Ion Torrent's chip-based genome sequencer is cheap, fast, and poised to revolutionize medicine mark for My Articles similar articles
Chemistry World
March 25, 2010
Leila Sattary
Science advice rules published The publication of the long-awaited principles for scientific advice in government has met with a frosty response, with some U. K. critics calling for researchers to boycott the guidelines. mark for My Articles similar articles
Scientific American
November 2007
Reviews Few books could present more implacably opposed views, and few could raise more provocative questions: The Case Against Perfection: Ethics in the Age of Genetic Engineering by Michael J. Sandel... Enhancing Evolution: The Ethical Case for Making Better People by John Harris... mark for My Articles similar articles
Chemistry World
January 28, 2015
Rebecca Trager
Roche chases bolt-on acquisitions as it pushes into genomics A recent spending spree by Roche is intended to take advantage of emerging molecular information and genomic analysis, as the company anticipates that the field will play an increasingly important role for future medicines and diagnostics. mark for My Articles similar articles